mob

Search This Blog

468x60

728

728x90

468,

250

250+300onk

We conducted a quality improvement project to determine whether education and computerized prescriber order entry

 


ABSTRACT


INTRODUCTION: Previous studies suggest that quality improvement initiatives focused on hospital-acquired venous thromboembolism have a positive impact on prescribing rates of venous thromboembolism prophylaxis, especially those that incorporate computerized changes.


METHODS: We conducted a quality improvement project to determine whether education and computerized prescriber order entry system changes affect venous thromboembolism prophylaxis compliance rates in hospitalized medical patients at a Comprehensive Cancer Center. Between 1 January 2021 and 31 January 2023, 37,739 non-surgical, adult patient encounters with a length of stay > 48 h were analyzed in our study. From 18 December 2021 to 8 March 2022, provider education was delivered to the three largest admitting services, and computerized prescriber order entry changes were implemented incorporating a mandatory requirement to either order venous thromboembolism prophylaxis or document a contraindication for all patients at moderate venous thromboembolism risk.


RESULTS: Monthly venous thromboembolism prophylaxis compliance rates, as defined by the Centers for Medicare and Medicaid Services VTE-1 metric, increased from a mean of 74% to 93% after the interventions. This change was driven primarily by an increased utilization of mechanical venous thromboembolism prophylaxis from 37% to 53%.


CONCLUSION: Our study demonstrated that a multi-faceted intervention incorporating provider education and computerized prescriber order entry system changes can significantly increase venous thromboembolism prophylaxis compliance rates in cancer patients.


PMID:37801550 | DOI:10.1177/10781552231205779

12:58

PubMed articles on: Cancer & VTE/PE

12:58

PubMed articles on: Cancer & VTE/PE

A - 119 A Case Study: the Cognitive Functioning of an Adult Patient with Recurrent Craniopharyngiomas

12:58

PubMed articles on: Cardio-Oncology

12:58

PubMed articles on: Cancer & VTE/PE

12:58

PubMed articles on: Cancer & VTE/PE

Increased risk of venous and arterial thromboembolism in patients with colorectal cancer receiving cetuximab-based combination chemotherapy: A population-based study in Korea

12:58

PubMed articles on: Cancer & VTE/PE

12:58

PubMed articles on: Cardio-Oncology

12:58

PubMed articles on: Cancer & VTE/PE

Artificial intelligence in the prediction of venous thromboembolism: A systematic review and pooled analysis

12:58

PubMed articles on: Cardio-Oncology

12:58

PubMed articles on: Cancer & VTE/PE

12:59

PubMed articles on: Cardio-Oncology

12:59

PubMed articles on: Cardio-Oncology

12:59

PubMed articles on: Cardio-Oncology

12:59

PubMed articles on: Cardio-Oncology

12:59

PubMed articles on: Cardio-Oncology

12:59

PubMed articles on: Cardio-Oncology

12:59

PubMed articles on: Cardio-Oncology

12:59

PubMed articles on: Cancer & VTE/PE

Anticoagulation and venous thromboembolism in patients aged 90 years and older: Data from the RIETE registry

12:59

PubMed articles on: Cancer & VTE/PE

Impact of venous thromboembolism on the mortality in patients with cancer: a population-based cohort study

12:59

PubMed articles on: Cancer & VTE/PE

17:07

Cardiotoxicity News

PubMed articles on: Cardio-Oncology

Irbesartan ameliorates inflammation via transendothelial leukocyte migration due to VCAM-1/NOX-1 signaling in cisplatin-induced cardiotoxicity


Iran J Basic Med Sci. 2023;26(11):1298-1304. doi: 10.22038/IJBMS.2023.70997.15422.

No comments:

Post a Comment

اكتب تعليق حول الموضوع

ACERUMEN، زجاجة جرعة واحدة

  جديد   عرض تقديمي 10 زجاجات الموزع أو الشركة المصنعة زينيث فارما تعبير عوامل التوتر السطحي الخفيفة (أسيل ساركوزينات الصوديوم وإستر السكروز...

Search This Blog